Gene · 7408
Papers3,538
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
681 to 700 of 3,538
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Catalytically active inclusion bodies (CatIBs) induced by terminally attached self-assembling coiled-coil domains: To enhance the stability of (R)-hydroxynitrile lyase. | Enzyme Microb Technol | 2022 | 34670185 | PubTator, text mining | PubMed |
| Molecular implications of HOX genes targeting multiple signaling pathways in cancer. | Cell Biol Toxicol | 2022 | 34617205 | PubTator, text mining | PubMed |
| Resistin and Cardiovascular Disease: A Review of the Current Literature Regarding Clinical and Pathological Relationships. | Curr Cardiol Rev | 2022 | 34325643 | PubTator, text mining | PubMed |
| Study on potential differentially expressed genes in stroke by bioinformatics analysis. | Neurol Sci | 2022 | 34313877 | PubTator, text mining | PubMed |
| Autocrine regulation of airway smooth muscle contraction by diacylglycerol kinase. | J Cell Physiol | 2022 | 34278583 | PubTator, text mining | PubMed |
| Polymerization power: effectors of actin polymerization as regulators of T lymphocyte migration through complex environments. | FEBS J | 2022 | 34273243 | PubTator, text mining | PubMed |
| Cyclic GMP modulating drugs in cardiovascular diseases: mechanism-based network pharmacology. | Cardiovasc Res | 2022 | 34270705 | PubTator, text mining | PubMed |
| Impact of chronic kidney disease on the pharmacodynamic and pharmacokinetic effects of ticagrelor in patients with diabetes mellitus and coronary artery disease. | Eur Heart J Cardiovasc Pharmacother | 2022 | 34114623 | PubTator, text mining | PubMed |
| Angiotensin II augments renal vascular smooth muscle soluble GC expression via an AT1 receptor-forkhead box subclass O transcription factor signalling axis. | Br J Pharmacol | 2022 | 33963547 | PubTator, text mining | PubMed |
| Novel CTRP8-RXFP1-JAK3-STAT3 axis promotes Cdc42-dependent actin remodeling for enhanced filopodia formation and motility in human glioblastoma cells. | Mol Oncol | 2022 | 33960104 | PubTator, text mining | PubMed |
| Glucagon-like peptide-1 (GLP-1) receptor agonists and their cardiovascular benefits-The role of the GLP-1 receptor. | Br J Pharmacol | 2022 | 33764504 | PubTator, text mining | PubMed |
| Keyphrase Extraction for Technical Language Processing. | J Res Natl Inst Stand Technol | 2021 | 39081638 | PubTator, text mining | PubMed |
| A shortcut to the thermodynamic limit for quantum many-body calculations of metals. | Nat Comput Sci | 2021 | 38217186 | PubTator, text mining | PubMed |
| Single-molecule localization microscopy. | Nat Rev Methods Primers | 2021 | 35663461 | PubTator, text mining | PubMed |
| Unraveling the site-specific energy transfer driven tunable emission characteristics of Eu3+ & Tb3+ co-doped Ca10(PO4)6F2 phosphors. | RSC Adv | 2021 | 35496828 | PubTator, text mining | PubMed |
| Phosphorylation of RIAM Activates Its Adaptor Function in Mediating Integrin Signaling. | J Cell Signal | 2021 | 35128538 | PubTator, text mining | PubMed |
| Platelet Mechanobiology Inspired Microdevices: From Hematological Function Tests to Disease and Drug Screening. | Front Pharmacol | 2021 | 35126120 | PubTator, text mining | PubMed |
| MiR-654-3p Constrains Proliferation, Invasion, and Migration of Sinonasal Squamous Cell Carcinoma via CREB1/PSEN1 Regulatory Axis. | Front Genet | 2021 | 35096015 | PubTator, text mining | PubMed |
| Tracking Immunoglobulin Repertoire and Transcriptomic Changes in Germinal Center B Cells by Single-Cell Analysis. | Front Immunol | 2021 | 35095922 | PubTator, text mining | PubMed |
| Cancer Chemoprevention: A Strategic Approach Using Phytochemicals. | Front Pharmacol | 2021 | 35095521 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7408/papers?page=35